Mergers & Acquisitions - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

1 to 25 of 642 results

Sun Pharma to buy GSK’s opiates business in Australia

Sun Pharma to buy GSK’s opiates business in Australia

03-03-2015

UK pharma major GlaxoSmithKline and India’s largest drugmaker by sales, Sun Pharmaceutical Industries,…

AustraliaGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalSun Pharmaceutical Industries

GSK and Novartis complete major three-part transaction

02-03-2015

UK pharma major GlaxoSmithKline said this morning that its three-part transaction with Swiss peer Novartis…

GlaxoSmithKlineMergers & AcquisitionsNovartisOncologyPharmaceuticalVaccines

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

28-02-2015

Anglo-Swedish pharma major AstraZeneca is changing the structure of its small-molecule early-stage anti-infectives…

Antibiotics and Infectious diseasesAstraZenecaMergers & AcquisitionsPharmaceuticalResearchUK

2015 outlook for US and EU pharma; report

2015 outlook for US and EU pharma; report

27-02-2015

According to this Global Pharma US & EU Outlook 2015 report, strategy diversification stays divested…

EuropeManagementMarkets & MarketingMergers & AcquisitionsPatentsPharmaceuticalUSA

Takeda acquires 13 products from Turkish company Neutec

Takeda acquires 13 products from Turkish company Neutec

25-02-2015

Takeda GmbH, the wholly-owned subsidiary of Japanese drugmaker Takeda has signed an agreement to obtain…

Markets & MarketingMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalTurkey

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

24-02-2015

The US Federal Trade Commission has put conditions on the proposed acquisition by Novartis of GlaxoSmithKline’s…

Array BioPharmaGSKLegalMergers & AcquisitionsNovartisOncologyPharmaceuticalRegulationResearchUSA

Marathon Pharma sells non-strategic products to Valeant

24-02-2015

Marathon Pharmaceuticals, a privately held US biopharmaceuticals company focused on drugs for people…

Marathon PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesValeant Pharmaceuticals International

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

Bristol-Myers Squibb to acquire Flexus; inks deal with Rigel

23-02-2015

US pharma major Bristol-Myers Squibb has signed a definitive agreement to acquire all of the outstanding…

Bristol-Myers SquibbF001287FlexusLicensingMergers & AcquisitionsOncologyPharmaceuticalRigel Pharmaceuticals

UPDATE: Valeant confirms $10 billion offer for Salix

UPDATE: Valeant confirms $10 billion offer for Salix

23-02-2015

Acquisitive Canadian drugmaker Valeant Pharmaceutical International late Sunday confirmed it has reached…

Gastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceuticals International

Valeant in final stages of making $10 billion offer for Salix; reports

Valeant in final stages of making $10 billion offer for Salix; reports

22-02-2015

Acquisitive Canadian drugmaker Valeant Pharmaceutical International could announce an around $10 billion…

Gastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceuticals International

Fresenius Kabi sells German oncology compounding business

Fresenius Kabi sells German oncology compounding business

17-02-2015

Fresenius Kabi, a unit of the Germany-headquartered Fresenius Group, has sold its German subsidiary CFL…

CFLFreseniusFresenius KabiGermanyMergers & AcquisitionsNewCo PharmaOncologyPharmaceutical

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

11-02-2015

UK pharma major GlaxoSmithKline this morning said that it has acquired Switzerland-based GlycoVaxyn,…

GlaxoSmithKlineGlycoVaxynMergers & AcquisitionsPharmaceuticalVaccines

Roche acquires Germany’s Signature Diagnostics

Roche acquires Germany’s Signature Diagnostics

10-02-2015

Swiss cancer drugs giant Roche has acquired Signature Diagnostics, a privately-held company based in…

Mergers & AcquisitionsOncologyPharmaceuticalRocheSignature Diagnostics

Cipla enters joint venture in Morocco and eyes Serum Institute of India merger

Cipla enters joint venture in Morocco and eyes Serum Institute of India merger

09-02-2015

Indian pharma company Cipla has announced that its UK subsidiary has entered into a joint venture agreement…

CiplaLicensingMarkets & MarketingMergers & AcquisitionsMoroccoPharmaceutical

GlobalData analyst views implications of Pfizer’s acquisition of Hospira

07-02-2015

Just days after gaining US Food and Drug Administration breakthrough approval for Ibrance (palbociclib)…

BiosimilarsHospiraMergers & AcquisitionsPfizerPharmaceutical

Valeant increases its offer to remain lead bidder in Dendreon 'stalking horse' acquisition

Valeant increases its offer to remain lead bidder in Dendreon 'stalking horse' acquisition

05-02-2015

Quebec, Canada-based Valeant Pharmaceuticals has entered into an amended agreement to remain lead bidder…

CanadaDendreonMergers & AcquisitionsPharmaceuticalProvengeValeant

The Medicines Company acquires Annovation Biopharma

05-02-2015

US drugmaker The Medicines Company says it has completed its acquisition of all of the outstanding equity…

Annovation BiopharmaMergers & AcquisitionsPharmaceuticalThe Medicines Company

Aspen buys rights to an anti-coagulant product from Novartis

26-01-2015

Aspen Global Inc, a wholly-owned subsidiary of South Africa’s Aspen Holdings, has entered into an agreement…

Aspen Global IncAspen HoldingsHematologyMergers & AcquisitionsMono-EmbolexNovartisPharmaceutical

Salix reportedly pursing acquisition, pushed by shareholders

Salix reportedly pursing acquisition, pushed by shareholders

21-01-2015

USA-based Salix Pharmaceuticals is reportedly pursuing acquisition by a large drugmaker.

Mergers & AcquisitionsPharmaceuticalReutersSalix PharmaceuticalsUSA

US FTC approves final order preserving in nicotine patches market competition

US FTC approves final order preserving in nicotine patches market competition

21-01-2015

Following a public comment period, the USA’s Federal Trade Commission has approved a final order settling…

GlaxoSmithKlineHabitrolMergers & AcquisitionsNeurologicalNovartisPharmaceuticalRegulationUSA

WuXi acquires NextCODE Health in $65 million cash deal

WuXi acquires NextCODE Health in $65 million cash deal

16-01-2015

Shanghai-headquartered pharmatech company WuXi has acquired NextCODE Health, a genomic analysis and bioinformatics…

ChinaMergers & AcquisitionsNextCODE HealthPharmaceuticalWuXi PharmaTech

GlobalData believes Shire-NPS deal to be 'robust'

GlobalData believes Shire-NPS deal to be 'robust'

15-01-2015

Ireland-headquartered drugmaker Shire’s deal to acquire NPS Pharmaceuticals is ‘robust’, according…

GattexGlobalDataMergers & AcquisitionsNatparaNPS PharmaceuticalsPharmaceuticalRare diseasesResearchShire

Tianyin Pharma to form strategic alliance with Buchang Pharma

15-01-2015

Tianyin Pharmaceutical says TPI and Buchang Pharmaceutical plan to establish Tianyin-Buchang Strategic…

Buchang PharmaceuticalCardio-vascularChinaGingko MihuanMergers & AcquisitionsPharmaceuticalProductionTianyin Pharmaceutical

2014 a memorable year for M&A activity in pharma sector

2014 a memorable year for M&A activity in pharma sector

15-01-2015

2014 was a busy year for merger and acquisition activity in the pharmaceutical industry, but will be…

GlobalMergers & AcquisitionsPfizerPharmaceuticalShire

1 to 25 of 642 results

Back to top